लोड हो रहा है...

Botulinum neurotoxin type A inhibits synaptic vesicle 2 expression in breast cancer cell lines

Aim: It is known that botulinum neurotoxin type A (BoNTA) improves some kinds of cancer (e.g. prostate) and that synaptic vesicle glycoprotein 2 (SV2) is the molecular target of this neurotoxin. Besides having potential therapeutic value, this glycoprotein has recently been proposed as a molecular m...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Int J Clin Exp Pathol
मुख्य लेखकों: Bandala, C, Cortés-Algara, AL, Mejía-Barradas, CM, Ilizaliturri-Flores, I, Dominguez-Rubio, R, Bazán-Méndez, CI, Floriano-Sánchez, E, Luna-Arias, JP, Anaya-Ruiz, M, Lara-Padilla, E
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: e-Century Publishing Corporation 2015
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4555739/
https://ncbi.nlm.nih.gov/pubmed/26339411
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!